3 October 2016 - The MS Trust is disappointed that NICE does not intend to recommend that daclizumab (Zinbryta) be made ...
27 September 2016 - The TGA has approved Biogen's Zinbryta. ...
16 September 2016 - The ICER has updated the timeline of its review of disease-modifying therapies for patients with multiple sclerosis. ...
25 August 2016 - Unique treatment delivered in only two cycles one year apart. ...
18 July 2016 - The ICER has released an addendum to the draft scoping document on disease-modifying therapies for multiple sclerosis. ...
18 July 2016 - Merck today announced that the EMA has accepted for review the marketing authorisation application of the ...
5 July 2016 - Unique treatment delivered in only two cycles one year apart. ...
5 July 2016 - Zinbryta significantly reduced multiple measures of disease activity in patients with relapsing forms of multiple sclerosis. ...
27 May 2016 - The U.S. FDA today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple ...
9 December 2015 - Funding for two new medicines will provide patients with more convenient options for treating multiple sclerosis. ...
4 December 2015 - PHARMAC is pleased to announce the approval of proposals to fund two new treatments for Multiple Sclerosis ...
11 September 2015 -Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials ...